CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Genentech against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFERNov 15, 2021

Explore Genentech's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 7, 2024Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of Use1
Jan 3, 2024Process For Concentration Of Antibodies And Therapeutic Products Thereof1
Nov 1, 2023Adjuvant Treatment Of Her2-Positive Breast Cancer4
Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof5
Mar 1, 2023Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides9
Jan 18, 2023Process For Concentration Of Antibodies And Therapeutic Products Thereof2
Jun 30, 2021Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof5
Apr 28, 2021Method For The Reduction Of Host Cell Proteins In Affinity Chromatography4
Sep 30, 2020Subcutaneous Her2 Antibody Formulations4
Aug 5, 2020Protein Purification1

Top competitors of Genentech

List of top competitors of Genentech based on patent oppositions.